Michael John Scott Saunders

This inventor holds 24 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Immunotherapy Biologics. Top assignees: Ablynx N.v., Merck Patent Gmbh, Argen-X N.v.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael John Scott Saunders. Retrieved from https://idiyas.com/inventor/michael-john-scott-saunders

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 15)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 20)

Average Co-Inventor Count = 6.4

ph-index = 7

Forward Citations = 203(Granted Patents)

Company Filing History:

Years Active: 2013-2024

Loading Chart...

Areas of Expertise:

Amino Acid Sequences

Polypeptides

Antibodies

IL-17A

CD70

Angiogenesis

GPCR

Viral Diseases

Chemokines

Immune System

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11858997 - Amino acid sequences that modulate the interaction between cells of the immune system (2024-01-02),

2. 11773159 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same (2023-10-03),

3. 11434298 - Antibodies to CD70 (2022-09-06),

4. 11072665 - Antibodies to CD70 (2021-07-27),

5. 10844123 - Amino acid sequences that modulate the interaction between cells of the immune system (2020-11-24),

6. 10829552 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same (2020-11-10),

7. 10208115 - Amino acid sequences that modulate the interaction between cells of the immune system (2019-02-19),

8. 10087251 - Amino acid sequences that modulate the interaction between cells of the immune system (2018-10-02),

9. 10017568 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using same (2018-07-10),

10. 9822175 - Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis (2017-11-21),

11. 9803018 - Amino acid sequences directed against cellular receptors for viruses and bacteria (2017-10-31),

12. 9765149 - Antibodies to CD70 (2017-09-19),

13. 9765148 - Antibodies to CD70 (2017-09-19),

14. 9512236 - Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders (2016-12-06),

15. 9382333 - Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis (2016-07-05),

Title: The Innovative Journey of Michael John Scott Saunders

Introduction:

Michael John Scott Saunders is a visionary inventor based in Brussels, Belgium. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of technology through his inventive spirit and dedication to progress.

Latest Patents:

Michael John Scott Saunders holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology. His innovative ideas have led to the development of cutting-edge products that have revolutionized their respective industries.

Career Highlights:

Throughout his illustrious career, Michael John Scott Saunders has worked with leading tech companies and research institutions to bring his inventions to life. His expertise in patent law and his keen eye for detail have ensured that his creations are protected and recognized on a global scale.

Collaborations:

Michael John Scott Saunders has collaborated with top engineers, scientists, and designers to enhance the impact of his inventions. By fostering a culture of innovation and teamwork, he has been able to push the boundaries of what is possible in the world of technology.

Conclusion:

In conclusion, Michael John Scott Saunders stands as a beacon of creativity and ingenuity in the field of invention. His relentless pursuit of innovation and his commitment to excellence continue to inspire the next generation of inventors to dream big and create a better future for all.

Profile summary based on public USPTO records.